Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs

Atherosclerosis

Volumn 234, Issue 2, 2014, Pages 346-351

  Zanoli, Luca ^a   Rastelli, Stefania ^a   Inserra, Gaetano ^a   Lentini, Paolo ^b   Valvo, Enrico ^c   Calcagno, Emanuela ^a   Boutouyrie, Pierre ^d   Laurent, Stephane ^d   Castellino, Pietro ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b San Bassiano Hospital   (Italy)

^c Umberto I Hospital   (Italy)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

IBD; Inflammation; Pulse wave velocity; PWV; TNF alpha

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; IMMUNOMODULATING AGENT; SALICYLIC ACID DERIVATIVE; STEROID; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; AUTACOID; GASTROINTESTINAL AGENT; IMMUNOSUPPRESSIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APPLANATION TONOMETER; ARTERIAL STIFFNESS; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; IMMUNOTHERAPY; INFLAMMATORY BOWEL DISEASE; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MIDDLE AGED; OBSERVATIONAL STUDY; OSCILLOMETER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSE WAVE; RADIAL ARTERY; RELAPSE; SPHYGMOMANOMETER; ULCERATIVE COLITIS; ANTAGONISTS AND INHIBITORS; BLOOD; COLITIS, ULCERATIVE; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; RECURRENT DISEASE; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; C-REACTIVE PROTEIN; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR STIFFNESS; YOUNG ADULT;

EID: 84900861070     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.03.023     Document Type: Article

References (33)

1. Geerling B.J., Badart-Smook A., Stockbrügger R.W., Brummer R.J. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 2000, 54:514-521.
2. Levy E., Rizwan Y., Thibault L., Lepage G., Brunet S., Bouthillier L., et al. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr 2000, 71:807-815.
3. Jahnsen J., Falch J.A., Mowinckel P., Aadland E. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol 2003, 98:1556-1562.
4. Yarur A.J., Deshpande A.R., Pechman D.M., Tamariz L., Abreu M.T., Sussman D.A. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol 2011, 106(4):741-747.
5. Haapamäki J., Roine R.P., Turunen U., Färkkilä M.A., Arkkila P.E. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. JCrohns Colitis 2011, 5(1):41-47.
6. Zanoli L., Cannavò M., Rastelli S., Di Pino L., Monte I., Di Gangi M., et al. Arterial stiffness is increased in patients with inflammatory bowel disease. JHypertens 2012, 30:1775-1781.
7. Mäki-Petäjä K.M., Hall F.C., Booth A.D., Wallace S.M.L., Yasmin, Bearcroft P.W.P., et al. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation 2006, 114:1185-1192.
8. Mäki-Petäjä K.M., Elkhawad M., Cheriyan J., Joshi F.R., Ostör A.J., Hall F.C., et al. Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation 2012, 126(21):2473-2480.
9. Moreau K.L., Deane K.D., Meditz A.L., Kohrt W.M. Tumor necrosis factor-α inhibition improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women. Atherosclerosis 2013, 230:390-396.
10. Kelly Rp, Hayward Cs, Ganis J., Daley Jm, Avolio Ap, O'Rourke Mf Non-invasive registration of the arterial pulse waveform using high-fidelity applanation tonometry. JVasc Med Biol 1989, 1:142-149.
11. Laurent S., Cockcroft J., Van Bortel L., Boutouyrie P., Giannattasio C., Hayoz D., et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006, 27(21):2588-2605.
12. Van Bortel L.M., Laurent S., Boutouyrie P., Chowienczyk P., Cruickshank J.K., De Backer T., et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. JHypertens 2012, 30:445-448. on behalf of the Artery Society, the European Society of Hypertension Working Group on Vascular Structure and Function and the European Network for Noninvasive Investigation of Large Arteries.
13. Harvey R.F., Bradshaw M.J. Asimple index of Crohn's-disease activity. Lancet 1980, 1(8167):514.
14. Pietri P., Vyssoulis G., Vlachopoulos C., Zervoudaki A., Gialernios T., Aznaouridis K., et al. Relationship between low-grade inflammation and arterial stiffness in patients with essential hypertension. JHypertens 2006, 24(11):2231-2238.
15. Yasmin, McEniery C.M., Wallace S., Mackenzie I.S., Cockcroft J.R., Wilkinson I.B. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004, 24:969-974.
16. Roman M.J., Devereux R.B., Schwartz J.E., Lockshin M.D., Paget S.A., Davis A., et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 2005, 46(1):194-199.
17. Booth A.D., Wallace S., McEniery C.M., Yasmin, Brown J., Jayne D.R., et al. Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 2004, 50:581-588.
18. Schillaci G., De Socio G., Pucci G., Mannarino M.R., Helou J., Pirro M., et al. Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension 2008, 52:308-313.
19. Vlachopoulos C., Dima I., Aznaouridis K., Vasiliadou C., Ioakeimidis N., Aggeli C., et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflection in healthy individuals. Circulation 2005, 112:2193-2200.
20. Karlinger K., Györke T., Makö E., Mester A., Tarján Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 2000, 35(3):154-167.
21. Yu Y., Sitaraman S., Gewirtz A.T. Intestinal epithelial cell regulation of mucosal inflammation. Immunol Res 2004, 29(1-3):55-68.
22. Papa A., Danese S., Urgesi R., Grillo A., Guglielmo S., Roberto I., et al. Early atherosclerosis in patients with inflammatory bowel disease. Eur Rev Med Pharmacol Sci 2006, 10(1):7-11.
23. van Leuven S.I., Hezemans R., Levels J.H., Snoek S., Stokkers P.C., Hovingh G.K., et al. Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease. JLipid Res 2007, 48(12):2640-2646.
24. Papa A., Santoliquido A., Danese S., Covino M., Di Campli C., Urgesi R., et al. Increased carotid intima-media thickness in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005, 22(9):839-846.
25. Danese S., Sgambato A., Papa A., Scaldaferri F., Pola R., Sans M., et al. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol 2005, 100(4):886-895.
26. Bregenzer N., Hartmann A., Strauch U., Schölmerich J., Andus T., Bollheimer L.C. Increased insulin resistance and beta cell activity in patients with Crohn's disease. Inflamm Bowel Dis 2006, 12(1):53-56.
27. Horowitz S., Binion D.G., Nelson V.M., Kanaa Y., Javadi P., Lazarova Z., et al. Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2007, 292:G1323-G1336.
28. Schinzari F., Armuzzi A., De Pascalis B., Mores N., Tesauro M., Melina D., et al. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease. Clin Pharmacol Ther 2008, 83(1):70-76.
29. Wilkinson I.B., Qasem A., McEniery C.M., Webb D.J., Avolio A.P., Cockcroft J.R. Nitric oxide regulates local arterial distensibility invivo. Circulation 2002, 105:213-217.
30. Dorn S.D., Sandler R.S. Inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol 2007, 102(3):662-667.
31. Hurlimann D., Forster A., Noll G., Enseleit F., Chenevard R., Distler O., et al. Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002, 106:2184-2187.
32. Booth A.D., Jayne D.R., Kharbanda R.K., McEniery C.M., Mackenzie I.S., Brown J., et al. Infliximab improves endothelial dysfunction in systemic vasculitis: a model of vascular inflammation. Circulation 2004, 109:1718-1723.
33. Bradford-Hill A.B. The environment and disease: association or causation. Proc R Soc Med 1965, 58:295-300.